Stuart A. Lipton, M.D., Ph.D. is recognized here as a Redox Pioneer because of his publication of four articles that have been cited more than 1000 times, and 96 reports which have been cited more than 100 times. In the redox field, Dr. Lipton is best known for his work on the regulation by S-nitrosylation of the NMDA-subtype of neuronal glutamate receptor, which provided early evidence for in situ regulation of protein activity by S-nitrosylation and a prototypic model of allosteric control by this post-translational modification. Over the past several years, Lipton's group has pioneered the discovery of aberrant protein nitrosylation that may contribute to a number of neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis (Lou Gehrig's disease). In particular, the phenotypic effects of rare genetic mutations may be understood to be enhanced or mimicked by nitrosative (and oxidative) modifications of cysteines and thereby help explain common sporadic forms of disease. Thus, Lipton has contributed in a major way to the understanding that nitrosative stress may result from modifications of specific proteins and may operate in conjunction with genetic mutation to create disease phenotype. Lipton (collaborating with Jonathan S. Stamler) has also employed the concept of targeted S-nitrosylation to produce novel neuroprotective drugs that act at allosteric sites in the NMDA receptor. Lipton has won a number of awards, including the Ernst Jung Prize in Medicine, and is an elected fellow of the AAAS. Antioxid. Redox Signal. 19, 757–764.
Get full access to this article
View all access options for this article.
References
1.
AizenmanE, LiptonSA, LoringRH. Selective modulation of NMDA responses by reduction and oxidation. Neuron, 2:1257–1263. 1989.
2.
AlirezaeiM, WatryDD, FlynnCF, KiossesWB, MasliahE, WilliamsBR, KaulM, LiptonSA. Human immunodeficiency virus-1/surface glycoprotein 120 induces apoptosis through RNA-activated protein kinase signaling in neurons. J Neurosci, 27:11047–11055. 2007.
3.
AnkarcronaM, DypbuktJM, BonfocoE, ZhivotovskyB, OrreniusS, LiptonSA, NicoteraP. Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial integrity. Neuron, 15:961–973. 1995.
4.
AwobuluyiM, YangJ, YeY, ChattertonJE, GodzikA, LiptonSA, ZhangD. Subunit-specific roles of glycine-binding domains in activation of NR1/NR3 N-methyl-d-aspartate receptors. Mol Pharmacol, 71:112–122. 2007.
5.
BarsoumMJ, YuanH, GerencserAA, LiotG, KushnarevaY, GräberS, KovacsI, LeeWD, WaggonerJ, CuiJ, WhiteAD, BossyB, MartinouJ-C, YouleRJ, LiptonSA, EllismanMH, PerkinsGA, Bossy-WetzelE. Nitric oxide-induced mitochondrial fission is regulated by dynamin related GTPases in neurons. EMBO J, 25:3900–3911. 2006.
6.
BonfocoE, KraincD, AnkarcronaM, NicoteraP, LiptonSA. Apoptosis and necrosis: two distinct events induced respectively by mild and intense insults with NMDA or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci U S A, 92:7162–7166. 1995.
7.
BonfocoE, LeistM, ZhivotovskyB, OrreniusS, LiptonSA, NicoteraP. Cytoskeletal breakdown and apoptosis elicited by NO-donors in cerebellar granule cells require NMDA-receptor activation. J Neurochem, 67:2484–2493. 1996.
8.
Bossy-WetzelE, TalantovaMV, LeeWD, SchölzkeMN, HarropA, MathewsE, GötzT, HanJ, EllismanMH, PerkinsGA, LiptonSA. Cross-talk between nitric oxide and zinc pathways to neuronal cell death involving mitochondrial dysfunction and p38-activated K+ channels. Neuron, 41:351–365. 2004.
9.
BuddSL, TennetiL, LishnakT, LiptonSA. Mitochondrial and extramitochondrial apoptotic signaling pathways in cerebrocortical neurons. Proc Natl Acad Sci U S A, 97:6161–6166. 2000.
10.
BukrinskyMI, NottetHSLM, SchmidtmayerovaH, DubrovskyL, FlanaganCR, MullinsME, LiptonSA, GendelmanHE. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: Implications for HIV-associated neurological disease. J Exp Med, 181:735–745. 1995.
11.
ChenH-SV, LiptonSA. Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism. J Physiol (Lond), 499:27–46. 1997.
12.
ChenH-SV, LiptonSA. Pharmacological implications of two distinct mechanisms of interaction of memantine with NMDA-gated channels. J Pharmacol Exp Ther, 314:961–971. 2005.
13.
ChenH-SV, PellegriniJW, AggarwalSK, LeiSZ, WarachS, JensenFE, LiptonSA. Open-channel block of NMDA responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. J Neurosci, 12:4427–4436. 1992.
14.
ChenH-SV, WangYF, RayuduPY, EdgecombP, NeillJC, SegalMM, LiptonSA, JensenFE. Neuroprotective concentrations of the NMDA open-channel blocker memantine are effective without cytoplasmic vacuolization following post-ischemic administration and do not block maze learning or LTP. Neuroscience, 86:1121–1132. 1998.
15.
ChoD-H, NakamuraT, FangJ, CieplakP, GodzikA, GuZ, LiptonSA. S-Nitrosylation of Drp1 mediates β-amyloid-related mitochondrial fission and neuronal injury. Science, 102–105. 2009.
16.
ChoiY-B, TennetiL, LeDA, OrtizJ, BaiG, ChenH-SV, LiptonSA. Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation. Nat Neurosci, 3:15–21. 2000.
17.
DreyerEB, KaiserPK, OffermannJT, LiptonSA. HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science, 248:364–367. 1990.
18.
DreyerEB, LiptonSA. The coat protein gp120 of HIV-1 inhibits astrocyte uptake of excitatory amino acids via macrophage arachidonic acid. Eur J Neurosci, 7:2502–2507. 1995.
19.
DreyerEB, ZurakowskiD, GorlaM, VorwerkCK, LiptonSA. The contribution of various nitric oxide synthase gene products to HIV-1 coat protein (gp120)-mediated retinal ganglion cell injury. Invest Ophthalmol Vis Sci, 40:983–989. 1999.
20.
FangJ, NakamuraT, ChoD-H, GuZ, LiptonSA. S-Nitrosylation of peroxiredoxin 2 (Prx2) promotes oxidative stress-induced neuronal cell death in Parkinson's disease. Proc Natl Acad Sci U S A, 104:18742–18747. 2007.
JaffreySR, Erdjument-BromageH, FerrisCD, TempstP, SnyderSH. Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat Cell Biol, 3:193–197. 2001.
25.
KaiserPK, OffermannJT, LiptonSA. Neuronal injury due to HIV-1 envelope protein is blocked by anti-gp120 antibodies but not by anti-CD4 antibodies. Neurology, 40:1757–1761. 1990.
26.
KarschinA, AizenmanE, LiptonSA. The interaction of agonists and noncompetitive antagonists at the excitatory amino acid receptors in rat retinal ganglion cells in vitro. J Neurosci Res, 8:2895–2906. 1988.
27.
KaulM, GardenGA, LiptonSA. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature, 410:988–994. 2001.
28.
KaulM, LiptonSA. Chemokines and activated macrophages in gp120-induced neuronal apoptosis. Proc Natl Acad Sci U S A, 96:8212–8216. 1999.
29.
KaulM, QingM, MeddersKE, LiptonSA. HIV-1 coreceptors CCR5 and CXCR4 both mediate neuronal cell death but CCR5 paradoxically can also contribute to neuroprotection. Cell Death Diff, 14:296–305. 2007.
30.
KikuchiM, TennetiL, LiptonSA. Role of p38 mitogen-activated protein kinase in axotomy-induced apoptosis of rat retinal ganglion cells. J Neurosci, 20:5037–5044. 2000.
31.
KimW-K, ChoiY-B, RayuduPV, DasP, AsaadW, ArnelleDR, StamlerJS, LiptonSA. Attenuation of NMDA receptor activity and neurotoxicity by nitroxyl (NO-)Neuron, 24:461–469. 1999.
32.
KwakYD, MaT, DiaoS, ZhangX, ChenY, HsuJ, LiptonSA, MasliahE, XuH, LiaoFF. NO signaling and S-nitrosylation regulate PTEN inhibition in neurodegeneration. Mol Neurodegener, 5:49. 2010.
33.
LeiSZ, PanZ-H, AggarwalSK, ChenH-SV, HartmanJ, SucherNJ, LiptonSA. Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. Neuron, 8:1087–1099. 1992.
34.
LevyDI, SucherNJ, LiptonSA. Redox modulation of NMDA receptor-mediated toxicity in mammalian central neurons. Neurosci Lett, 110:291–296. 1990.
LiptonSA. Calcium channel antagonists and human immunodeficiency virus coat protein-mediated neuronal injury. Neuron, 30:110–114. 1991.
37.
LiptonSA. 7-Chlorokynurenate ameliorates neuronal injury mediated by HIV envelope protein gp120 in rodent retinal cultures. Eur J Neurosci, 4:1411–1415. 1992.
38.
LiptonSA. Memantine prevents HIV coat protein-induced neuronal injury in vitro. Neurology, 42:1403–1405. 1992.
39.
LiptonSA. Models of neuronal injury in AIDS: another role for the NMDA receptor?Trends Neurosci, 15:75–79. 1992.
40.
LiptonSA. Requirement for macrophages in neuronal injury induced by HIV envelope protein gp120. NeuroReport, 3:913–915. 1992.
41.
LiptonSA. Human immunodeficiency virus-infected macrophages, gp120, and NMDA receptor-mediated neurotoxicity. Ann Neurol, 33:227–228. 1993.
42.
LiptonSA. Prospects for clinically-tolerated NMDA antagonists: open-channel blockers and alternative redox states of nitric oxide. Trends Neurosci, 16:527–532. 1993.
43.
LiptonSA. HIV coat protein gp120 induces soluble neurotoxins in culture medium. Neurosci Res Commun, 15:31–37. 1994.
44.
LiptonSA. Neurobiology: HIV displays its coat of arms. Nature, 367:113–114. 1994.
45.
LiptonSA. Janus Faces of NF-κB: neurodestruction versus neuroprotection. Nat Med, 3:20–22. 1997.
46.
LiptonSA. Concepts: turning down but not off—neuroprotection requires a paradigm shift in drug development. Nature, 428:473. 2004.
47.
LiptonSA. Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Nat Rev Drug Disc, 5:160–170. 2006.
48.
LiptonSA. Pathologically activated therapeutics for neuroprotection. Neurosci Lett, 8:803–808. 2007.
LiptonSA, ChoiY-B, PanZ-H, LeiSZ, ChenH-SV, SucherNJ, SingelDJ, LoscalzoJ, StamlerJS. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature, 364:626–632. 1993.
51.
LiptonSA, ChoiY-B, TakahashiT, ZhangD, LiW, GodzikA, BankstonLA. Cysteine regulation of protein function—as exemplified by NMDA-receptor modulation. Trends Neurosci, 25:474–480. 2002.
52.
LiptonSA, GendelmanHE. Dementia associated with the acquired immunodeficiency syndrome. N Engl J Med, 332:934–940. 1995.
53.
LiptonSA, NakamuraT, UeharaT, ShiZ-Q, GuZ. Comment on S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. Science, 308:1870. 2005.
54.
LiptonSA, RosenbergPA. Mechanisms of disease: excitatory amino acids as a final common pathway in neurologic disorders. N Engl J Med, 330:613–622. 1994.
55.
LiptonSA, StamlerJS, SingelDJ. NO comments. Nature, 367:28. 1994.
56.
LiptonSA, SucherNJ, KaiserPK, DreyerEB. Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron, 7:111–118. 1991.
57.
ManabeS, GuZ, LiptonSA. Activation of matrix metalloproteinase-9 via neuronal nitric oxide synthase contributes to NMDA-induced retinal ganglion cell death. Invest Ophthalmol Vis Sci, 46:4747–4753. 2005.
58.
ManabeS, LiptonSA. NMDA-induced divergent signals leading to proapoptotic and antiapoptotic pathways in the rat retina. Invest Ophthalmol Vis Neurosci, 44:385–392. 2003.
NumajiriN, TakasawaK, NishiyaT, HayakawaW, AsadaM, MatsudaH, AzumiK, TanakaH, HyakkokuK, KamataH, NakamuraT, HaraM, LiptonSA, UeharaT. On-off system for PI3-kinase-Akt signaling through S-nitrosylation of phosphatase with sequence homology to tensin (PTEN)Proc Natl Acad Sci U S A, 108:10349–10354. 2011.
OkamotoS-i, LiZ, JuC, SchölzkeMN, MatthewsE, CuiJ, SalvesenGS, Bossy-WetzelE, LiptonSA. Dominant-interfering forms of MEF2 generated by caspase cleavage contribute to NMDA-induced neuronal apoptosis. Proc Natl Acad Sci U S A, 99:3974–3979. 2002.
65.
PanZ-H, BähringR, GrantynR, LiptonSA. Differential modulation by sulfhydryl redox agents and glutathione of GABA- and glycine-evoked currents in rat retinal ganglion cells. J Neurosci Res, 15:1384–1391. 1995.
66.
PellegriniJW, LiptonSA. Delayed administration of memantine prevents NMDA receptor-mediated neurotoxicity. Ann Neurol, 33:403–407. 1993.
67.
QuJ, NakamuraT, CaoG, HollandEA, McKercherSR, LiptonSA. S-Nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by β-amyloid peptide. Proc Natl Acad Sci U S A, 108:14330–14335. 2011.
68.
SatohT, AkhtarMW, LiptonSA. Combatting oxidative/nitrosative stress with electrophilic counterattack strategies. Oxidative Stress and Redox Regulation. JakobUH, ReichmannD.P Springer(In Press).
69.
SatohT, KosakaK, ItohK, KobayashiA, YamamotoM, ShimojoY, KitajimaC, CuiJ, KaminsJ, OkamotoSI, IzumiM, ShirasawaT, LiptonSA. Carnosic acid, a catechol-type electrophilic compound, protects neurons both in vitro and in vivo through activation of the Keap1/Nrf2 pathway via S-alkylation of targeted cysteines on Keap1. J Neurochem, 104:1116–1131. 2008.
70.
SatohT, LiptonSA. Redox regulation of neuronal survival mediated by electrophilic compounds. Trends Neurosci, 30:37–45. 2007.
71.
SatohT, OkamuraS-i, CuiJ, WatanabeY, FurutaK, SuzukiM, TohyamaK, LiptonSA. Activation of the Keap1/Nrf2 pathway for neuroprotection by electrophilic phase II inducers. Proc Natl Acad Sci U S A, 103:768–773. 2006.
72.
SatohT, RazieT, SekiM, TabuchiT, KitagawaT, YanagitaiM, SenzakiM, KosegawaC, TairaH, McKercherSR, HoffmanJK, RothGP, LiptonSA. Dual neuroprotective pathways of a pro-electrophilic compound via HSF-1-activated heat-shock proteins and Nrf2-activated phase 2 antioxidant response enzymes. J Neurochem, 119:569–578. 2011.
73.
StamlerJS, TooneEJ, LiptonSA, SucherNJ. (S)NO signals: translocation, regulation and a consensus motif. Neuron, 18:691–696. 1997.
74.
StiegPE, SathiS, WarachS, LeDA, LiptonSA. Neuroprotection by the NMDA open-channel blocker memantine in a photothrombotic model of cerebral focal ischemia in neonatal rat. Eur J Pharmacol, 375:115–120. 1999.
75.
SucherNJ, LiptonSA. Redox modulatory site of the NMDA receptor-channel complex: regulation by oxidized glutathione. J Neurosci Res, 30:582–591. 1991.
76.
SucherNJ, WongLA, LiptonSA. Redox modulation of NMDA receptor-mediated Ca2+ flux in mammalian central neurons. NeuroReport, 1:29–32. 1990.
77.
SullivanJM, TraynelisSF, ChenHSV, EscobarW, HeinemannSF, LiptonSA. Identification of two cysteine residues that are required for redox modulation of the NMDA subtype of glutamate receptor. Neuron, 13:929–936. 1994.
78.
TakahashiH, ShinY, ChoS-J, ZagoWM, NakamuraT, GuZ, MaY, FurukawaH, LiddingtonRL, ZhangD, TongG, ChenH-SV, LiptonSA. Hypoxia enhances S-nitrosylation—mediated NMDA receptor inhibition via a thiol oxygen sensor motif. Neuron, 53:53–64. 2007.
79.
TennetiL, D'EmilaDM, LiptonSA. Suppression of neuronal apoptosis by S-nitrosylation of caspases. Neurosci Lett, 236:139–142. 1997.
80.
TennetiL, D'Emila, TroyCM, LiptonSA. Role of caspases in N-methyl-D-aspartate-induced apoptosis in cerebrocortical neurons. J Neurochem, 71:946–959. 1998.
81.
TennetiL, LiptonS. Involvement of activated caspase-3-like proteases in N-methyl-d-aspartate-induced apoptosis in cerebrocortical neurons. J Neurochem, 74:134–142. 2000.
82.
UeharaT, NakamuraT, YaoD, ShiZ-Q, GuZ, MasliahE, NomuraY, LiptonSA. S-Nitrosylation of protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature, 441:513–517. 2006.
83.
WangY, EuJ, WashburnM, GongT, ChenH-SV, JamesWL, LiptonSA, StamlerJS, WentGT, PorterS. The pharmacology of aminoadamantane nitrates. Curr Alzheimer Res, 3:201–204. 2006.
84.
XiaP, ChenH-SV, ZhangD, LiptonSA. Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses. J Neurosci, 30:11246–11250. 2010.
85.
YaoD, GuZ, NakamuraT, ShiZ-Q, MaY, GastonB, PalmerLA, RockensteinEM, ZhangZ, MasliahE, UeharaT, LiptonSA. Nitrosative stress linked to sporadic Parkinson's disease: S-Nitrosylation of parkin regulates it E3 ligase activity. Proc Natl Acad Sci U S A, 101:10810–10814. 2004.
86.
YehM, KaulM, ZhengJ, NottetHSLM, ThylinM, GendelmanHE, LiptonSA. Cytokine-stimulated, but not HIV-infected, human monocyte-derived macrophages produce neurotoxic levels of l-cysteine. J Immunol, 164:4265–4270. 2000.
87.
ZhaoY, NaviaBA, MarraCM, SingerEJ, ChangL, BergerJ, EllisRJ, KolsonDL, SimpsonD, MillerEN, LiptonSA, EvansSR, SchifittoG. the Adult AIDS Clinical Trial Group (ACTG) 301 Team. Memantine for AIDS dementia complex: open-label report of ACTG 301. HIV Clin Trials, 11:59–67. 2010.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
